Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Novel Combination of Ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-Reactive Protein Serum Levels in Patients With Migraine: A Randomized Clinical Trial Study Publisher Pubmed



Abdolahi M1, 2 ; Sarraf P3 ; Javanbakht MH2 ; Honarvar NM2 ; Hatami M2 ; Soveyd N2 ; Tafakhori A3 ; Sedighiyan M4 ; Djalali M5 ; Jafarieh A1 ; Masoudian Y1 ; Djalali M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. AmirAlam Hospital Complex, Marvasti Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Iranian Centre of Neurological Research, Department of Neurology, Imam Khomeini Hospital Tehran, University of Medical Sciences Tehran, Iran
  4. 4. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

Source: CNS and Neurological Disorders - Drug Targets Published:2018


Abstract

Background: Migraine is a disabling neuroinflammatory condition characterized by increasing the levels of interleukin (IL)-6, a proinflammatory cytokine and C-reactive protein (CRP) which considered as a vascular inflammatory mediator, disrupting the integrity of blood-brain barrier and contributing to neurogenic inflammation, and disease progression. Curcumin and ω-3 fatty acids can exert neuroprotective effects through modulation of IL-6 gene expression and CRP levels. The aim of present study is the evaluation of combined effects of ω-3 fatty acids and nano-curcumin supplementation on IL-6 gene expression and serum level and hs-CRP levels in migraine patients. Methods: Eighty episodic migraine patients enrolled in the trial and were divided into four groups as 1) combination of ω-3 fatty acids (2500 mg) plus nano-curcumin (80 mg), 2) ω-3 (2500 mg), 3) nanocurcumin (80 mg), and 4) the control (ω-3 and nano-curcumin placebo included oral paraffin oil) over a two-month period. At the beginning and the end of the study, the expression of IL-6 from peripheral blood mononuclear cells and IL-6 and hs-CRP serum levels were measured, using a real-time PCR and ELISA methods, respectively. Results: The results showed that both of ω-3 and nano-curcumin down-regulated IL-6 mRAN and significantly decreased the serum concentration. hs-CRP serum levels significantly decrease in combination and nano-curcumin within groups (P<0.05). An additive greater reduction of IL-6 and hs-CRP was observed in the combination group suggested a possible synergetic relation. Conclusion: It seems that ω-3 fatty acids and curcumin supplementation can be considered a new promising target in migraine prevention. © 2018 Bentham Science Publishers.
Experts (# of related papers)
Other Related Docs
10. Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences, Endocrine# Metabolic and Immune Disorders - Drug Targets (2019)
12. Dietary Supplementation in Migraine: A Focus on Omega-3 Fatty Acids, Treatments# Nutraceuticals# Supplements# and Herbal Medicine in Neurological Disorders (2023)
14. Review on Headache Related to Dietary Supplements, Current Pain and Headache Reports (2022)
20. Evaluation of Inflammatory State in Migraineurs: A Case-Control Study, Iranian Journal of Allergy# Asthma and Immunology (2020)
30. Association of Diet and Headache, Journal of Headache and Pain (2019)